Herbert Y Meltzer Selected Research

cariprazine

11/2019	The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens.
1/2017	New Trends in the Treatment of Schizophrenia.
12/2015	Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herbert Y Meltzer Research Topics

Disease

180	Schizophrenia (Dementia Praecox) 04/2024 - 03/2002
43	Weight Gain 10/2023 - 01/2002
43	Psychotic Disorders (Schizoaffective Disorder) 04/2022 - 01/2002
31	Cognitive Dysfunction 03/2024 - 03/2002
28	Tardive Dyskinesia 04/2024 - 07/2002
17	Treatment-Resistant Schizophrenia 11/2023 - 11/2003
12	Obesity 10/2019 - 08/2004
9	Bipolar Disorder (Manic Depressive Psychosis) 11/2019 - 09/2003
8	Dyskinesias (Dyskinesia) 10/2020 - 07/2003
6	Hallucinations (Hallucination) 01/2021 - 05/2003
6	Movement Disorders (Movement Disorder) 01/2021 - 09/2003
6	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2003
5	Body Weight (Weight, Body) 10/2023 - 01/2003
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 12/2005
5	Catalepsy 10/2017 - 05/2003
4	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 03/2002
4	Memory Disorders (Memory Loss) 10/2023 - 02/2016
3	Diabetes Mellitus 01/2023 - 06/2004
3	Mood Disorders (Mood Disorder) 01/2016 - 07/2003
3	Psychomotor Agitation (Akathisia) 12/2015 - 02/2010
3	Agranulocytosis (Granulocytopenia) 10/2012 - 09/2003
2	Genetic Risk Score 01/2023 - 01/2018
2	Mental Disorders (Mental Disorder) 04/2022 - 01/2015
2	Torsades de Pointes (Torsade de Pointes) 03/2019 - 01/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2006
2	Weight Loss (Weight Reduction) 10/2017 - 05/2010
2	Neurobehavioral Manifestations 10/2017 - 02/2011
2	Substance-Related Disorders (Drug Abuse) 03/2015 - 08/2002
2	Inflammation (Inflammations) 05/2014 - 09/2010

Drug/Important Bio-Agent (IBA)

134	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2002
77	Clozapine (Clozaril)FDA LinkGeneric 11/2023 - 03/2002
40	Olanzapine (Zyprexa)FDA Link 10/2023 - 08/2002
23	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 09/2003
19	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 08/2002
17	Phencyclidine (Angel Dust)IBA 10/2023 - 05/2003
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 03/2004
10	Lurasidone Hydrochloride FDA Link 01/2021 - 09/2011
10	ziprasidone (Geodon)FDA Link 03/2019 - 10/2003
10	Haloperidol (Haldol)FDA LinkGeneric 01/2017 - 05/2004
10	Quetiapine Fumarate (Seroquel)FDA Link 03/2010 - 09/2003
9	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 08/2002
9	Cholinergic Agents (Cholinergics)IBA 12/2017 - 03/2002
9	N-Methylaspartate (NMDA)IBA 02/2017 - 05/2003
7	EnzymesIBA 10/2020 - 11/2005
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
7	Serotonin ReceptorsIBA 12/2013 - 03/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2005
6	Aripiprazole (Abilify)FDA Link 01/2021 - 02/2007
6	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020 - 07/2003
6	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 07/2006
6	Proteins (Proteins, Gene)FDA Link 11/2018 - 03/2009
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2015 - 05/2009
5	metylperon (melperone)IBA 05/2020 - 01/2003
5	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 01/2003
5	Glutamic Acid (Glutamate)FDA Link 10/2018 - 09/2010
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017 - 05/2008
4	Triglycerides (Triacylglycerol)IBA 01/2023 - 12/2011
4	norclozapineIBA 12/2017 - 04/2005
4	ProlactinIBA 01/2011 - 01/2003
4	Perphenazine (Trilafon)FDA LinkGeneric 01/2009 - 07/2006
3	HDL CholesterolIBA 01/2023 - 12/2011
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2002
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 11/2018
3	pimavanserinIBA 01/2020 - 03/2010
3	cariprazineIBA 11/2019 - 12/2015
3	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2019 - 09/2007
3	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 01/2009
3	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2016 - 04/2010
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 02/2007
3	5-HT2C Serotonin ReceptorIBA 03/2015 - 11/2010
3	tandospironeIBA 07/2013 - 05/2007
3	Adrenergic Agents (Adrenergic Drugs)IBA 08/2011 - 03/2003
3	Amino Acids FDA Link 02/2011 - 03/2004
3	AntioxidantsIBA 12/2009 - 11/2005
3	5-HT1A Serotonin ReceptorIBA 03/2009 - 01/2007
3	Glutamate Receptors (Glutamate Receptor)IBA 09/2005 - 05/2003
2	Genetic Markers (Genetic Marker)IBA 04/2024 - 07/2012
2	serpentine (alkaloid)IBA 10/2023 - 06/2015
2	Insulin (Novolin)FDA Link 01/2023 - 04/2010
2	GLYX-13 peptideIBA 01/2022 - 02/2016
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2020 - 11/2013
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2017 - 04/2005
2	CholesterolIBA 11/2017 - 12/2005
2	Amphetamine (Amfetamine)FDA LinkGeneric 10/2017 - 01/2009
2	lorcaserinIBA 10/2017 - 12/2013
2	Amisulpride (Solian)IBA 01/2017 - 07/2009
2	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2017 - 01/2017
2	Ketamine FDA LinkGeneric 02/2016 - 11/2013
2	Levodopa (L Dopa)FDA LinkGeneric 11/2014 - 04/2010
2	Dizocilpine Maleate (Dizocilpine)IBA 11/2013 - 02/2011
2	Buspirone (Buspar)FDA LinkGeneric 07/2013 - 09/2007
2	Serotonin 5-HT1 Receptor AgonistsIBA 05/2012 - 09/2007
2	Monoamine Oxidase (MAO)IBA 08/2011 - 05/2010
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2010 - 06/2010
2	Oxytocin (Pitocin)FDA LinkGeneric 08/2010 - 07/2010
2	LipidsIBA 04/2010 - 01/2002

Therapy/Procedure

7	Therapeutics 03/2016 - 01/2003
2	Injections 01/2018 - 08/2015
2	Drug Therapy (Chemotherapy) 02/2017 - 02/2007
2	Duration of Therapy 05/2014 - 02/2013